GO:2000845 positive regulation of testosterone secretion: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000845 describes any biological process that increases the rate, frequency, or extent of testosterone secretion, the steroid hormone produced mainly by Leydig cells of the testis.
• Testosterone secretion is controlled by the hypothalamic-pituitary-gonadal axis, with luteinizing hormone (LH) as the primary acute stimulus of Leydig cell steroidogenesis.
• Emerging evidence shows that m6A mRNA methylation and autophagy are critical intracellular regulators of testosterone synthesis in Leydig cells.
• Exercise, diet, and body composition can modulate free testosterone and cortisol levels in young men, linking lifestyle to GO:2000845.
• Osteocalcin has been proposed as a positive regulator of testosterone when the preeminent hypothalamic-pituitary regulation is impaired, as seen in spinal cord injury.
• CRISPR-based knockout, knock-in, point-mutation, and overexpression models are powerful tools to dissect causal genes in the positive regulation of testosterone secretion.
Description
Testosterone is the principal androgen in males and plays essential roles in muscle protein metabolism, bone density, and reproductive function. The amount of testosterone secreted into circulation is tightly controlled by endocrine and local factors, and the Gene Ontology term GO:2000845 (positive regulation of testosterone secretion) captures the biological processes that increase this secretion. Understanding this term is important for researchers studying male hypogonadism, anabolic resistance, and metabolic disorders. The positive regulation of testosterone secretion involves hypothalamic-pituitary signaling, Leydig cell steroidogenic machinery, and emerging post-transcriptional mechanisms such as m6A mRNA methylation and autophagy. This article integrates authoritative GO annotation with verified PubMed literature to provide a research-grade overview of GO:2000845, its key genes, disease relevance, and experimental models.
positive regulation of testosterone secretion At A Glance
| GO ID | GO:2000845 |
|---|---|
| GO term | positive regulation of testosterone secretion |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Upregulation of testosterone release from Leydig cells and other steroidogenic tissues |
| Primary regulators | Luteinizing hormone (LH), m6A methylation, autophagy, osteocalcin |
| Associated cell types | Leydig cells, adrenal cortical cells, ovarian theca cells |
| Disease relevance | Hypogonadism, spinal cord injury, metabolic syndrome, infertility |
What Is GO:2000845?
GO:2000845, positive regulation of testosterone secretion, is a biological process term that encompasses any mechanism that increases the frequency, rate, or extent of testosterone secretion. Testosterone secretion refers to the regulated release of testosterone from cells, primarily testicular Leydig cells, into the extracellular space or bloodstream. Positive regulation can occur through endocrine signals such as luteinizing hormone (LH), paracrine factors, or intracellular pathways that enhance steroidogenic enzyme expression or cholesterol transport. This term is distinct from testosterone biosynthesis, as it specifically refers to the secretion step and its upregulation.
Why Is positive regulation of testosterone secretion Important in Cell Biology?
The positive regulation of testosterone secretion is critical for male reproductive health, muscle mass maintenance, bone density, and overall metabolic homeostasis. Disruption of this process leads to low testosterone levels, which are associated with fatigue, reduced muscle mass, osteoporosis, and infertility. Moreover, understanding how testosterone secretion is positively regulated can inform therapeutic strategies for hypogonadism and age-related testosterone decline.
• Maintains male secondary sexual characteristics and reproductive function.
• Supports muscle protein synthesis and muscle growth.
• Regulates bone mineral density and prevents osteoporosis.
• Influences body composition, including fat distribution and lean mass.
• Modulates mood, energy, and cognitive function.
• Plays a role in metabolic syndrome and insulin sensitivity.
• Is impaired in spinal cord injury, unmasking alternative regulators like osteocalcin.
• Dysregulation contributes to hypogonadism and infertility.
• m6A methylation and autophagy are emerging intracellular checkpoints.
• Therapeutic targeting of positive regulators may restore testosterone levels.
What Happens During positive regulation of testosterone secretion?
Hypothalamic-pituitary stimulation
In simple terms: The brain signals the testes to make more testosterone.
The hypothalamus releases gonadotropin-releasing hormone (GnRH), which stimulates the anterior pituitary to secrete luteinizing hormone (LH). LH binds to its receptor on Leydig cells, activating cAMP-dependent signaling and cholesterol transport into mitochondria, the rate-limiting step in testosterone synthesis and secretion. This endocrine axis is the primary positive regulator of testosterone secretion in healthy men.
Leydig cell steroidogenic activation
In simple terms: Inside the testes, specialized cells turn cholesterol into testosterone and release it.
Upon LH stimulation, Leydig cells upregulate the expression and activity of steroidogenic acute regulatory protein (STAR), cytochrome P450 family 11 subfamily A member 1 (CYP11A1), and 3-beta-hydroxysteroid dehydrogenase (HSD3B), leading to increased testosterone production and secretion. This process is tightly coupled to mitochondrial function and energy metabolism.
Post-transcriptional regulation by m6A methylation
In simple terms: Chemical tags on RNA can speed up or slow down testosterone production.
Recent studies show that m6A mRNA methylation regulates testosterone synthesis through modulating autophagy in Leydig cells. The m6A reader protein YTHDF2 and the demethylase FTO influence the stability of mRNAs encoding steroidogenic enzymes, thereby affecting testosterone secretion. FTO overexpression or knockdown alters testosterone levels in Leydig cells, highlighting a novel layer of positive regulation.
Autophagy and metabolic control
In simple terms: Cellular recycling processes can boost testosterone output.
Autophagy in Leydig cells is required for optimal testosterone synthesis; inhibition of autophagy reduces testosterone secretion, while its activation enhances it. This is linked to m6A methylation, as m6A modifications modulate autophagic flux. Additionally, osteocalcin, a bone-derived hormone, can positively regulate testosterone secretion when the hypothalamic-pituitary axis is impaired, as observed in spinal cord injury.
Lifestyle and systemic modulation
In simple terms: Exercise and diet can change how much testosterone is released.
Exercise and protein metabolism influence muscle growth and may indirectly affect testosterone secretion. A 2025 study found that lifestyle, diet, and body composition significantly affect free testosterone and cortisol levels in young men, suggesting that systemic factors can positively regulate testosterone secretion.
Key Genes Involved in GO:2000845 positive regulation of testosterone secretion
The following genes and proteins are experimentally implicated in the positive regulation of testosterone secretion, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LHCGR | Luteinizing hormone receptor on Leydig cells | Mediates LH-stimulated testosterone secretion |
| STAR | Cholesterol transport into mitochondria | Rate-limiting step in steroidogenesis |
| CYP11A1 | Cholesterol side-chain cleavage enzyme | Converts cholesterol to pregnenolone |
| HSD3B2 | 3-beta-hydroxysteroid dehydrogenase | Catalyzes testosterone precursor conversion |
| CYP17A1 | 17-alpha-hydroxylase | Produces androgen precursors |
| FTO | m6A demethylase | Regulates testosterone secretion via m6A modifications |
| YTHDF2 | m6A reader protein | Modulates mRNA stability of steroidogenic genes |
| METTL3 | m6A methyltransferase | Writes m6A marks on mRNAs affecting autophagy |
| BECN1 | Autophagy regulator | Influences autophagic flux in Leydig cells |
| MAP1LC3B | Autophagosome marker | Correlates with autophagic activity |
| BGLAP | Osteocalcin | Positive regulator when hypothalamic-pituitary axis is impaired |
| INSR | Insulin receptor | Links metabolic status to testosterone secretion |
| AKT1 | Akt signaling kinase | Mediates testosterone effects on muscle |
| MTOR | mTOR kinase | Integrates nutrient signals with steroidogenesis |
| FOXO3 | Forkhead box O3 | Regulates protein turnover in muscle |
| VEGFA | Vascular endothelial growth factor A | May influence testicular angiogenesis |
| CASP9 | Caspase-9 | Apoptosis regulator in testicular cells |
How Is positive regulation of testosterone secretion Regulated?
The positive regulation of testosterone secretion is controlled at multiple levels. Acutely, LH from the pituitary activates Leydig cell steroidogenesis via cAMP/PKA signaling. Chronically, m6A mRNA methylation and autophagy modulate the stability and translation of steroidogenic mRNAs. FTO, an m6A demethylase, regulates testosterone secretion in Leydig cells, and its therapeutic potential is being explored with hCG. Systemic factors such as osteocalcin can bypass the hypothalamic-pituitary axis to stimulate testosterone secretion in spinal cord injury. Lifestyle factors including diet and exercise also influence free testosterone levels.
positive regulation of testosterone secretion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FTO | Hypogonadism, metabolic syndrome | Leydig cell-specific FTO knockout mouse |
| LHCGR | Leydig cell hypoplasia | LHCGR knockout mouse |
| STAR | Lipoid congenital adrenal hyperplasia | STAR point-mutation knock-in |
| BGLAP | Spinal cord injury-induced hypogonadism | Osteocalcin overexpression mouse |
| METTL3 | Testicular dysfunction | Conditional METTL3 knockout in Leydig cells |
Hypogonadism and infertility
Impaired positive regulation of testosterone secretion leads to hypogonadism, characterized by low testosterone, reduced libido, and infertility. FTO-mediated m6A modifications are emerging as therapeutic targets for hypogonadism.
Spinal cord injury
In spinal cord injury, the preeminent hypothalamic-pituitary regulation of testosterone production is impaired, but osteocalcin can still positively regulate testosterone secretion, suggesting alternative pathways.
Metabolic syndrome and obesity
Body composition and lifestyle factors affect free testosterone and cortisol levels, linking metabolic syndrome to dysregulated testosterone secretion.
Muscle wasting and sarcopenia
Testosterone positively regulates muscle protein synthesis via Akt/mTORC1/FoxO3a signaling; reduced testosterone secretion contributes to muscle wasting.
From positive regulation of testosterone secretion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is FTO causally required for testosterone secretion? | FTO knockout in Leydig cells |
| Does a point mutation in STAR affect cholesterol transport? | STAR point-mutation knock-in |
| Can osteocalcin restore testosterone in spinal cord injury? | Osteocalcin overexpression in mice |
| What is the role of m6A reader YTHDF2 in steroidogenesis? | YTHDF2 tagged knock-in for RIP-seq |
| Does autophagy enhance testosterone secretion? | BECN1 overexpression in Leydig cells |
| How does LH receptor signaling affect testosterone? | LHCGR knockout and rescue |
How to Study the positive regulation of testosterone secretion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Identify steroidogenic genes regulated by FTO |
| m6A-seq | m6A methylation sites | Map m6A modifications on steroidogenic mRNAs |
| LC-MS/MS | Testosterone concentration | Quantify secretion in Leydig cell media |
| Western blot | Protein expression | Measure STAR, CYP11A1, HSD3B2 levels |
| Immunofluorescence | Protein localization | Visualize Leydig cell markers |
| Autophagy flux assay | Autophagic activity | Assess LC3B turnover in Leydig cells |
| CRISPR screen | Gene function | Identify novel regulators of testosterone secretion |
| Bioinformatics | Pathway enrichment | Analyze m6A and transcriptomic data |
Transcriptomic and epitranscriptomic profiling
RNA-seq and m6A-seq can identify mRNAs encoding steroidogenic enzymes that are differentially methylated or expressed upon positive regulation of testosterone secretion. These methods reveal FTO and METTL3 targets in Leydig cells.
Proteomic and phosphoproteomic analysis
Mass spectrometry-based proteomics can quantify steroidogenic enzymes and signaling proteins such as Akt and mTOR in response to testosterone secretagogues.
Functional assays for testosterone secretion
ELISA or LC-MS/MS can measure testosterone in culture media from Leydig cells or in serum from animal models after genetic or pharmacological manipulation.
Imaging and histological analysis
Immunofluorescence for CYP11A1 and HSD3B2 can visualize Leydig cell steroidogenic capacity, while autophagy markers like LC3B can be assessed by confocal microscopy.
How CRISPR Can Be Used to Study GO:2000845 positive regulation of testosterone secretion
Knockout
CRISPR knockout of candidate genes such as FTO, METTL3, or LHCGR in Leydig cell lines or mouse models can determine their requirement for positive regulation of testosterone secretion. For example, FTO knockout reduces testosterone secretion, confirming its positive role.
Point Mutation
Point mutations in STAR or CYP11A1 can mimic human mutations that impair cholesterol transport or enzyme activity, allowing researchers to study their impact on testosterone secretion.
Knock-in
Knock-in of tagged versions of YTHDF2 or METTL3 enables RNA immunoprecipitation to identify m6A-modified mRNAs involved in testosterone secretion.
Overexpression
Overexpression of osteocalcin or BECN1 can test whether increasing their levels enhances testosterone secretion in models of hypothalamic-pituitary impairment.
How EDITGENE Supports positive regulation of testosterone secretion Research
Researchers studying positive regulation of testosterone secretion-related genes often need to determine whether a candidate gene is causally involved in Leydig cell steroidogenesis or systemic testosterone control. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell and animal models, accelerating functional validation of genes implicated in GO:2000845.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of testosterone secretion research.
Frequently Asked Questions About positive regulation of testosterone secretion
What is GO:2000845?
GO:2000845 is the Gene Ontology term for positive regulation of testosterone secretion, describing any process that increases the rate or extent of testosterone release from cells.
What genes are involved in positive regulation of testosterone secretion?
Key genes include LHCGR, STAR, CYP11A1, HSD3B2, FTO, METTL3, YTHDF2, and BGLAP (osteocalcin).
How is testosterone secretion regulated?
It is primarily regulated by the hypothalamic-pituitary-gonadal axis via LH, and locally by m6A methylation, autophagy, and osteocalcin.
What is the role of m6A methylation in testosterone secretion?
m6A methylation regulates testosterone synthesis by modulating autophagy and mRNA stability of steroidogenic enzymes in Leydig cells.
Can lifestyle affect testosterone secretion?
Yes, diet, exercise, and body composition can influence free testosterone and cortisol levels in young men.
What diseases are associated with impaired testosterone secretion?
Hypogonadism, infertility, spinal cord injury, metabolic syndrome, and muscle wasting.
How can I study positive regulation of testosterone secretion?
Use CRISPR knockout, knock-in, overexpression models combined with RNA-seq, m6A-seq, and testosterone ELISAs.
What is the role of osteocalcin in testosterone secretion?
Osteocalcin can positively regulate testosterone secretion when the hypothalamic-pituitary axis is impaired, such as in spinal cord injury.
Which cell types secrete testosterone?
Leydig cells in the testes are the primary source, but adrenal and ovarian cells also secrete androgens.
What CRISPR models are available for studying testosterone secretion?
EDITGENE offers knockout, point mutation, knock-in, overexpression, and library screening models for genes like FTO, METTL3, and STAR.
Conclusion
GO:2000845, positive regulation of testosterone secretion, is a vital biological process with broad implications for male health, metabolism, and disease. The integration of endocrine signals, m6A epitranscriptomics, autophagy, and systemic factors like osteocalcin highlights its complexity. Advances in CRISPR modeling and multi-omics will continue to uncover novel regulators and therapeutic targets for testosterone-related disorders.
References
- 1. Bhasin S et al.. 2001. Testosterone dose-response relationships in healthy young men.. Am J Physiol Endocrinol Metab 281(6):E1172-81 PMID: 11701431
- 2. Tipton KD et al.. 2001. Exercise, protein metabolism, and muscle growth.. Int J Sport Nutr Exerc Metab 11(1):109-32 PMID: 11255140
- 3. Mazurkiewicz D et al.. 2025. Effects of Lifestyle, Diet, and Body Composition on Free Testosterone and Cortisol Levels in Young Men.. Nutrients 17(23) PMID: 41374062
- 4. Zhang H et al.. 2025. Shen-Ying-Yang-Zhen formula promotes angiogenesis around hair follicles, alleviates oxidative stress, and inhibits hair follicle apoptosis through the VEGF/Akt/Caspase-9 signaling axis.. Phytomedicine 145:156963 PMID: 40543232
- 5. Chen Y et al.. 2021. m(6)A mRNA methylation regulates testosterone synthesis through modulating autophagy in Leydig cells.. Autophagy 17(2):457-475 PMID: 31983283
- 6. White JP et al.. 2013. Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle.. Mol Cell Endocrinol 365(2):174-86 PMID: 23116773
- 7. Wang C et al.. 2025. FTO regulates testosterone secretion in Leydig cells: insights into the role of m(6)A modifications and the therapeutic potential of hCG.. Reprod Biol Endocrinol 23(1):121 PMID: 40993667
- 8. Barbonetti A et al.. 2019. Can the positive association of osteocalcin with testosterone be unmasked when the preeminent hypothalamic-pituitary regulation of testosterone production is impaired? The model of spinal cord injury.. J Endocrinol Invest 42(2):167-173 PMID: 29729005
